Genetic association of lipid metabolism related SNPs with myocardial infarction in the Pakistani population

Molecular Biology Reports

Volumn 41, Issue 3, 2014, Pages 1545-1552

  Iqbal, Riffat ^a   Jahan, Nusrat ^a   Sun, Yisuo ^b   Xue, Hong ^b  

^a GC UNIVERSITY   (Pakistan)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Haplotypes; Linkage disequilibrium; Lipids; Triglycerides

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGE; APOA5 GENE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENDER; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; PAKISTAN; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADULT; AGED; APOLIPOPROTEINS A; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PAKISTAN; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 84896037033     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-3000-x     Document Type: Article

References (30)

1. Shiffman D, Kane JP, Louie JZ, Arellano AR, Ross DA, Catanese JJ, MJ Malloy, Ellis SG, Devlin JJ (2008) Analysis of 17,576 potentially functional SNPs in three case-control studies of myocardial infarction. PLoS One 3(8):e2895
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365(9455):217-223 (Pubitemid 40138015)
3. Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, Pandey MR, Haque S, Mendis S, Rangaraian S, Yusuf SL (2007) Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 297:286-294 (Pubitemid 46143306)
4. Gholapa N, Daviesb M, Patel K, Sattard N, Khuntie K (2011) Type 2 diabetes and cardiovascular disease in South Asians. Prime Care Diab 5:45-56
5. Nuri MM, Nawaz A, Usman H (2006) A proposed study of risk factors of heart disease in rural population of Punjab (Pakistan)-time to act. Pak Heart J 39:3-4
6. Topol EJ, Smith J, Plow EF, Wang QK (2006) Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 15:R117-R123 (Pubitemid 44446784)
7. Wang Q (2005) Molecular genetics of coronary artery disease. Curr Opin Cardiol 20:182-188
8. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the interheart study): case-control study. Lancet 364:937-952 (Pubitemid 39208455)
9. Kathiresan S, Melander O, Guiducci C, Surti A et al (2008) Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40:189-197 (Pubitemid 351171402)
10. Kathiresan S, Voight BF, Purcell S, Musunuru K et al (2009) Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 41:334-341
11. Kooner JS, Chambers JC, Aguilar-Salinas CA, Hinds DA, Hyde CL, Warnes GR, Gómez Pérez FJ, Frazer KA, Elliott P, Scott J, Milos PM, Cox DR, Thompson JF (2008) Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat Genet 40:149-151 (Pubitemid 351171393)
12. Willer CJ, Sanna S, Jackson AU, Scuteri A et al (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40:161-169 (Pubitemid 351171403)
13. Waterworth DM, Ricketts SL, Song K, Chen L (2010) Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 30:2264-2276
14. Samani NJ, Erdmann J, Hall AS, Hengstenberg C et al (2007) Genome wide association analysis of coronary artery disease. N Engl J Med 357:443-453 (Pubitemid 47204873)
15. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294:169-173 (Pubitemid 32952971)
16. Lo WS, Harano M, Gawlik M, Yu Z, Chen J, Pun FW, Tong KL, Zhao C, Ng SK, Tsang SY, Uchimura N, Stober G, Xue H (2007) GABRB2 association with schizophrenia: commonalities and differences between ethnic groups and clinical subtypes. Biol Psychiatry 61:653-660 (Pubitemid 46328854)
17. Yu Z, Chen J, Shi H, Stoeber G, Tsang SY, Xue H (2006) Analysis of GABRB2 association with schizophrenia in German population with DNA sequencing and one-label extension method for SNP genotyping. Clinic Biochem 39:210-218
18. Raymond M, Rousset F (1995) Genepop (Version-1.2)-population-genetics software for exact tests and ecumenicism. J Hered 86:248-249
19. Li J, Xu HW, Zhu XY (2007) Association of APOA5 gene polymorphism with levels of lipids and atherosclerotic cerebral infarction. Chin J Med Genet 24:576-578 (Pubitemid 47597758)
20. Cullen P (2000) Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 86:943-949
21. Laurila PP, Naukkarinen J, Kristiansson K, Ripatti S, Kauttu T, Silander K, Salomaa V, Perola M, Karhunen PJ, Barter PH, Ehnohol C, Peltonen L (2010) Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis. Arterioscler Thromb Vasc Biol 30:346-352
22. Talmud PJ, Martin S, Taskinen MR, Frick MH, Nieminen MS, Kesaniemi YA, Pasternack A, Humphries SE, Syvanne M (2004) APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. J Lipid Res 45:750-756 (Pubitemid 38405682)
23. Murray CJ, Lopez AD (1997) Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349:1269-1276 (Pubitemid 27192468)
24. Austin MA, Talmud FM, Farin DA, Nickerson KL, Edwards D, Leonetti MJ, McNeely HM, Viernes SE, Humphries, Fujimoto WY (2004) Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans. Biochim Biophys Acta 1688:1-9
25. Palmen J, Smith AJ, Dorfmeister B, Putt W, Humphries SE, Talmud PJ (2008) The functional interaction on in vitro gene expression of APOA5 SNPs, defining haplotype APOA52, and their paradoxical association with plasma triglyceride but not plasma apo AV levels. Biochim Biophys Acta 1782:447-452
26. Ken-Dror G, Goldbourt U, Dankner R (2010) Different effects of apolipoprotein A5 SNPs and haplotypes on triglyceride concentration in three ethnic origins. Hum Genet 55(5):300-307
27. Linsel-Nitschke P, Heeren J, Aherrahrou Z et al (2010) Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDLuptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis 208:183-189
28. Saleheen D, Soranzo N, Rasheed A, Scharnagl H et al (2010) Genetic determinants of major blood lipids in Pakistan compared with Europeans. Circ Cardiovasc Genet 3:348-357
29. Lu Qi, Jiantao, Qi Qibin, Hartiala J et al (2011) Genetic risk score and risk of myocardial infarction in hispanics. Circulation 123:374-380
30. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R et al (2012) Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 380(9841):572-580